Results 11 to 20 of about 2,340 (196)

Benign central neurocytoma [PDF]

open access: yesCancer, 2000
"Central neurocytoma" is classically considered as an intraventricular benign tumor, largely based on data from small retrospective series. The authors present prospective data on 12 patients with tumors diagnosed as central neurocytoma, to highlight the diverse nature of this tumor and challenge the classic notion.Between 1991 and 1997, 12 patients ...
K, Ashkan   +4 more
openaire   +4 more sources

Diffuse midline glioma, H3K27-altered, mimicking central neurocytoma on MRI: A case report [PDF]

open access: yesRadiology Case Reports
Diffuse midline glioma (DMG), H3K27-altered, is an aggressive central nervous system tumor that usually arises in midline structures such as the pons, thalamus, or spinal cord.
Yasuyuki Kojita, MD, PhD   +8 more
doaj   +2 more sources

Clinical Outcome After Microsurgical Resection of Central Neurocytoma: A Single-Centre Analysis of 15 Years [PDF]

open access: yesFrontiers in Neurology, 2021
Objective: This study aimed to explore the immediate postoperative and long-term outcomes of central neurocytoma (CN) based on 15 years of experience in our institution.Methods: This single-institution study collected data of 43 patients with CN who ...
Dan Cao   +4 more
doaj   +2 more sources

Central Neurocytoma: A Review of Clinical Management and Histopathologic Features. [PDF]

open access: yesBrain Tumor Res Treat, 2016
Central neurocytoma (CN) is a rare, benign brain tumor often located in the lateral ventricles. CN may cause obstructive hydrocephalus and manifest as signs of increased intracranial pressure. The goal of treatment for CN is a gross total resection (GTR),
Lee SJ   +10 more
europepmc   +4 more sources

Systematic Analysis of Clinical Outcomes Following Stereotactic Radiosurgery for Central Neurocytoma. [PDF]

open access: yesBrain Tumor Res Treat, 2017
Central neurocytoma (CN) typically presents as an intraventricular mass causing obstructive hydrocephalus. The first line of treatment is surgical resection with adjuvant conventional radiotherapy.
Bui TT   +7 more
europepmc   +3 more sources

Central neurocytoma exhibits radial glial cell signatures with FGFR3 hypomethylation and overexpression [PDF]

open access: yesExperimental and Molecular Medicine
We explored the genomic events underlying central neurocytoma (CN), a rare neoplasm of the central nervous system, via multiomics approaches, including whole-exome sequencing, bulk and single-nuclei RNA sequencing, and methylation sequencing.
Yeajina Lee   +22 more
doaj   +2 more sources

Central neurocytoma

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2013
HAN Tong
doaj   +4 more sources

Central Neurocytoma Diagnosis on Squash Cytology

open access: yesJournal of Cytology
Shruti Gupta   +3 more
doaj   +2 more sources

Central neurocytomas [PDF]

open access: yesCancer, 1997
This analysis was performed to examine the outcome of patients with histologically confirmed central neurocytomas.Thirty-two patients with histologically confirmed central neurocytomas were evaluated retrospectively. Patients were treated with various combinations of surgery, chemotherapy, and radiotherapy (RT). Follow-up ranged from 2.3 to 15.3 years (
S E, Schild   +6 more
openaire   +2 more sources

Features of complex therapeutical rehabilitation management with favorable evolution in a patient with right hemiplegia, mixed aphasia and optic atrophy post surgical removal of be-nign intraventricular tumor (central neurocytoma) [PDF]

open access: yesBalneo and PRM Research Journal, 2022
Central neurocytoma (CN) is a benign brain tumor located intraventricularly and classified as grade II by the World Health Organization in 2000 (classification of tumours of the central nerv-ous system).
Elena-Madalina Mocanu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy